The World Health Organization’s (WHO) recommendation for the widespread use of the RTS,S/AS01 (Mosquirix) vaccine in 2021 marked a monumental milestone in public health—it was the first vaccine ever approved for a human parasitic disease. Developed by GSK through decades of research, RTS,S primarily targets the Plasmodium falciparum parasite, which is responsible for the majority of...